These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 362141)

  • 1. Rubella vaccination in Australia: 2. Experience with the RA27/3 rubella vaccine and results of a double-blind trial in schoolgirls.
    Menser MA; Forrest JM; Bransby RD; Collins E
    Med J Aust; 1978 Jul; 2(3):85-8. PubMed ID: 362141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
    Grillner L
    Scand J Infect Dis; 1975; 7(3):169-72. PubMed ID: 1237176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
    J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.
    Freestone DS; Reynolds GM; McKinnon JA; Prydie J
    Br J Prev Soc Med; 1975 Dec; 29(4):258-61. PubMed ID: 766879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella screening and vaccination programme at a Melbourne maternity hospital. A five-year review.
    Francis BH; Hatherley LI; Walstab JE; Taft LI
    Med J Aust; 1982 Jun; 1(12):502-4. PubMed ID: 7099091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women.
    Tingle AJ; Mitchell LA; Grace M; Middleton P; Mathias R; MacWilliam L; Chalmers A
    Lancet; 1997 May; 349(9061):1277-81. PubMed ID: 9142061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rubella vaccination in Australia.
    Menser MA; Hudson JR; Murphy AM; Cossart YE
    Lancet; 1984 May; 1(8385):1059-62. PubMed ID: 6143984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    Kańtoch M; Rudnicka H; Imbs D
    Przegl Epidemiol; 1985; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract]   [Full Text] [Related]  

  • 12. Rubella vaccination in Australia: 1. A five-year follow-up of vaccinated schoolgirls.
    Menser MA; Forrest JM; Bransby RD
    Med J Aust; 1978 Jul; 2(3):83-5. PubMed ID: 713933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal risk associated with rubella vaccine: an update.
    Bart SW; Stetler HC; Preblud SR; Williams NM; Orenstein WA; Bart KJ; Hinman AR; Herrmann KL
    Rev Infect Dis; 1985; 7 Suppl 1():S95-102. PubMed ID: 4001743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Japanese rubella vaccine: comparative trials.
    Best JM; Banatvala JE; Bowen JM
    Br Med J; 1974 Jul; 3(5925):221-4. PubMed ID: 4602899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella prevention in family practice with RA27/3 vaccine.
    Hansen NH
    J Fam Pract; 1980 Oct; 11(4):537-42. PubMed ID: 7420029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella vaccination and congenital rubella syndrome in Western Australia.
    Condon RJ; Bower C
    Med J Aust; 1993 Mar; 158(6):379-82. PubMed ID: 8479351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella viraemia and antibody responses after rubella vaccination and reimmunization.
    Balfour HH; Groth KE; Edelman CK; Amren DP; Best JM; Banatvala JE
    Lancet; 1981 May; 1(8229):1078-80. PubMed ID: 6112449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella screening and immunisation of schoolgirls: results six to seven years after vaccination.
    Zealley H; Edmond E
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):382-4. PubMed ID: 6800467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.